The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | Video pages | E-seminar | Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease

Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease

ERA Journal Club

 

Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease: a randomised controlled trial

Access the article here

Speaker
Sharlene Greenwood, United Kingdom

Panellists
Naomi Clyne, Sweden
Emilie Cornec-Le Gall, France

Moderators
Andreas Kronbichler, Austria
Amaryllis Van Craenenbroeck, Belgium

Thursday, March 27, 2025, 5:00 PM (CET)